| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.32M | - | |
| Other | 52.8K | $8.76M | - | |
| Other | 46.8K | $7.76M | - | |
| Other | 39.6K | $6.58M | -36,937 | |
| Other | 36.8K | $6.12M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2020 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 52,749 | $125.31 | $6,609,733.40 | -15.8% | |
| May 18, 2020 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 5,000 | $120.00 | $600,000.00 | -16.1% | |
| May 12, 2020 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 61,555 | $114.94 | $7,075,396.39 | -9.4% | |
| May 7, 2020 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 15,000 | $110.21 | $1,653,133.50 | -71.6% | |
| May 7, 2020 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 8,682 | $105.44 | $915,454.39 | -7.7% | |
| Apr 28, 2020 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,741 | $102.49 | $178,435.09 | -22.6% | |
| Apr 28, 2020 | Sherwin Stephen A | Director | Sell | 17,687 | $99.39 | $1,757,965.76 | -37.2% | |
| Apr 24, 2020 | Roberts Eiry49 | Chief Medical Officer | Sell | 1,934 | $99.47 | $192,376.33 | -17.0% | |
| Apr 24, 2020 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 1,934 | $99.45 | $192,329.14 | -7.2% | |
| Apr 24, 2020 | Lippoldt Darin60 | Chief Legal Officer | Sell | 1,934 | $99.49 | $192,415.98 | -6.9% |